Erbitux
Active Ingredient(s): CetuximabFDA Approved: * February 12, 2004
Pharm Company: * IMCLONE
Category: Cancer
Cetuximab is an epidermal growth factor receptor (EGFR) inhibitor medication used for the treatment of metastatic colorectal cancer and head and neck cancer. Cetuximab is a chimeric (mouse/human) monoclonal antibody given by intravenous infusion that is distributed under the trade name Erbitux in the U.S. and Canada by the drug company Eli Lilly and Co. and outside those countries by the drug company Merck KGaA. In Japan, Merck KGaA, Bristol-Myers Squibb and Eli Lilly have a co-distribution. ... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.1 Discussion
Dosage List
Popular Topics
Erbitux
I am about to start treatment for a HPV related tonsillar cancer and Erbitux is one of the drugs I will be treated with....